Medtronic received information that prior to the attempted implant of a transcatheter bioprosthetic valve, a pre-implant balloon aortic valvuloplasty (bav) with a 22-millimeter (mm) balloon (true dilatation balloon) was performed.The first two attempts at the bav resulted in the balloon migrating too high.On the third attempt at the bav, the annulus ruptured.Heart compressions were then initiated.An attempt was made to implant the valve to see if it could improve the patient condition.No improvement was observed, and the patient expired.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|